SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
41,450
-2,300 (-5.26%)
At close: Mar 9, 2026

SK bioscience Market Cap

SK bioscience has a market cap or net worth of 3.25 trillion as of March 9, 2026. Its market cap has decreased by -15.05% in one year.

Market Cap
3.25T
Enterprise Value
2.90T
Revenue
624.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
41,450.00

Market Cap Chart

Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.25T, a decrease of -74.85%. That is a compound annual growth rate of -24.22%.

History

DateMarket Cap% Change
Mar 9, 20263,251.12B-13.96%
Dec 30, 20253,778.45B-4.31%
Dec 30, 20243,948.70B-28.57%
Dec 28, 20235,528.45B-2.04%
Dec 29, 20225,643.63B-67.21%
Dec 30, 202117.21T33.14%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
PharmaResearch 3,459.75B
D&D Pharmatech 3,652.62B
Hugel 2,824.54B
OliX Pharmaceuticals 4,179.31B
Orum Therapeutics 2,490.56B
Voronoi 5,927.74B
Peptron 6,132.46B
Chabiotech 1,820.72B
Market Cap Rankings